Fig. 2

Trial schedule. ^*The Seattle Angina Questionnaire (SAQ) and Short Form-36 (SF-36) will be only measured in the six hospitals selected for economic evaluation. ^#The platelet aggregation and hypersensitivity C-reactive protein (hs-CRP) are to be tested in both control and treatment arm in one or two centers in Shanghai. ^aMajor adverse cardiovascular and cerebrovascular events (MACEs) include all-cause death, cardiovascular death, non-fatal myocardial infarction, stent thrombosis, revascularization, ischemic stroke, and rehospitalization for unstable angina. ^bRoutine tests include complete blood count, urinalysis, and stool tests. ^cIncludes levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, gamma-glutamyl transpeptidase, total bilirubin, and direct bilirubin. ^dCoagulation function includes levels of prothrombin time, thrombin time, international normalized ratio, activated partial thromboplastin time, and fibrinogen